However, endoscopy with biopsy is often essential ... The two types of IBD are: Ulcerative colitis (UC): affects the large intestine and rectum Crohn’s disease: can affect any part of the ...
SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...
Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...
Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...
46.7% in placebo 16.7% endoscopic remission in the itolizumab ... 2 clinical study of patients with moderate to severe ulcerative colitis and a Phase 1b clinical study of patients with lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results